logo
REGENXBIO to Host Webcast Discussing Interim Functional Data from the Phase I/II AFFINITY DUCHENNE® Trial of RGX-202

REGENXBIO to Host Webcast Discussing Interim Functional Data from the Phase I/II AFFINITY DUCHENNE® Trial of RGX-202

Yahoo02-06-2025
Event will feature Aravindhan Veerapandiyan, M.D., principal investigator of the AFFINITY DUCHENNE® trial
ROCKVILLE, Md., June 2, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a webcast to discuss new interim functional data from the Phase I/II AFFINITY DUCHENNE® trial of RGX-202, the company's next-generation investigational gene therapy for the treatment of Duchenne muscular dystrophy. The webcast will feature AFFINITY DUCHENNE principal investigator Aravindhan Veerapandiyan, M.D., Arkansas Children's Hospital.
Webcast detailsTitle: AFFINITY DUCHENNE® Trial of RGX-202: Phase I/II Interim Functional DataDate/Time: Thursday, June 5, 2025, at 8:00 a.m. EDT Access: The live webcast can be accessed here and in the Investors section of REGENXBIO's website at www.regenxbio.com. An archived replay of the webcast will be available for approximately 30 days following the presentation.
ABOUT REGENXBIO Inc.REGENXBIO is a biotechnology company on a mission to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the field of AAV gene therapy. REGENXBIO is advancing a late-stage pipeline of one-time treatments for rare and retinal diseases, including RGX-202 for the treatment of Duchenne; clemidsogene lanparvovec (RGX-121) for the treatment of MPS II and RGX-111 for the treatment of MPS I, both in partnership with Nippon Shinyaku; and surabgene lomparvovec (ABBV-RGX-314) for the treatment of wet AMD and diabetic retinopathy, in collaboration with AbbVie. Thousands of patients have been treated with REGENXBIO's AAV platform, including those receiving Novartis' ZOLGENSMA®. REGENXBIO's investigational gene therapies have the potential to change the way healthcare is delivered for millions of people. For more information, please visit www.REGENXBIO.com.
Contacts:
Dana CormackCorporate Communicationsdcormack@regenxbio.com
Investors:George E. MacDougallInvestor RelationsIR@regenxbio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/regenxbio-to-host-webcast-discussing-interim-functional-data-from-the-phase-iii-affinity-duchenne-trial-of-rgx-202-302470286.html
SOURCE REGENXBIO Inc.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Should You Buy Amazon Stock Before July 31?
Should You Buy Amazon Stock Before July 31?

Yahoo

time19 minutes ago

  • Yahoo

Should You Buy Amazon Stock Before July 31?

Amazon is caught in a tug-of-war between the growing demand for AI and macro and geopolitical factors. The accelerating adoption of AI and growth from the company's cloud and advertising businesses may be enough to offset weakness resulting from higher tariffs. Despite these challenges, Amazon has a long track record of growth and is selling at a discount to its historic valuation. 10 stocks we like better than Amazon › Second-quarter earnings season is about to hit the ground running, and to say investors will be sitting on the edge of their seats may be an understatement. One company that's caught in the underlying economic tug-of-war is Amazon (NASDAQ: AMZN). On the one hand, many of the products on the digital retailer's platform are sourced from around the world, so it's particularly vulnerable to the Trump administration's tariff agenda. On the other hand, the company's digital advertising business and its cloud segment -- Amazon Web Services (AWS) -- stand to gain from accelerating adoption of AI, which could be a significant catalyst for growth. The company faces a key hurdle when Amazon reports its second-quarter results, which are expected to be released on July 31. Given the competing economic forces at play, should investors buy Amazon stock ahead of this key financial report or wait until the results have been made public? Let's take a look to see what the evidence suggests. One of the biggest unknowns in the upcoming quarter is the impact of tariffs. Third-party merchants account for roughly 62% of unit sales, and many of those sellers source their goods from China. The U.S. announced a trade deal with China last month that set tariffs on Chinese goods at a minimum of 30%, though the levies on some products are higher. While this is down from the peak of 145%, the timing of the deal in early June suggests Amazon's second-quarter sales and profits will likely take a hit. However, the company expanded its Prime Day sale to four days, double the length of its member-only sale last year, which could boost sales. Unfortunately, the event began after the close of the second quarter, so the impact on any additional sales won't hit the financials until Q3. Results from the first quarter came in before the imposition of tariffs, and investors liked what they saw. Overall net sales increased 9% year over year to $155.7 billion, with 60% of its revenue coming from digital sales or third-party seller services. Investors will be watching closely to gauge the impact of tariffs on Amazon's biggest business. The news isn't all bad, as the breadth of Amazon's business will insulate the company somewhat from the trade war, starting with its cloud segment. AWS is the undisputed leader in cloud infrastructure services, controlling 32% of the market in the first quarter and growing 17% year over year, according to market analyst Canalys. It's also Amazon's biggest moneymaker, generating 19% of revenue and 63% of operating income. Growth has reignited over the past year or so, fueled by demand for AI. Last month, CEO Andy Jassy noted that Amazon had more than 1,000 generative AI services and applications in progress or built, with plans to develop many more, saying, "AI will be a substantial catalyst." This, in turn, could drive higher demand for AWS. Let's not forget Amazon's advertising, which has quickly become the company's fastest-growing business. Ad revenue grew 18% year over year in Q2, fueled by Amazon Prime and the company's live sports programming. Recent reports suggest marketers are moving millions in ad spending to Amazon's platform, according to advertising industry publication Adweek. Amazon's advertising business began as a way for the company to capitalize on the valuable digital real estate on its e-commerce platform, but has since expanded significantly. Earlier this year, advertising on Prime Video became standard, with users required to pay a $3 monthly fee to forego the ads. The company also gets ad revenue from Freevee, its other ad-supported streaming channel, and from Twitch, its live-streaming gaming platform. Amazon sought to expand its advantage, inking a groundbreaking deal with Roku to give advertisers "access to the largest authenticated CTV [connected TV] footprint in the U.S.," available exclusively through the Amazon Demand-Side Platform (DSP), which connects ad buyers with available advertising. Roku and Amazon reach combined reaches an estimated 80 million CTV households, which represents more than 80% of CTV households in the country, according to the press release. This could be a significant catalyst for ad growth going forward. I generally don't recommend making buying decisions based on arbitrary days on a calendar, but rather the totality of the circumstances and the opportunities that could fuel revenue and profit growth. Each of Amazon's major business segments is growing at a respectable clip, and the proliferation of AI could act as an ongoing catalyst. Wall Street is nearly unanimous in its bullish view of Amazon. Of the 70 analysts who have offered an opinion in July, 66 -- a whopping 94% -- rate the stock a buy or strong buy, and none recommend selling. Furthermore, the average price target of $242 suggests there's additional upside of 8% compared to Friday's closing price. However, just this week, analysts at Morgan Stanley lifted their price target on Amazon to $300, which represents 33% potential upside for investors. The analysts called Amazon a "top pick" and cited more manageable tariffs, cloud growth, and strength across its AI offerings as fueling the firm's bullish call. Amazon is the undisputed leader in e-commerce and cloud infrastructure services and a key player in digital advertising. Add to that the company's portfolio of AI offerings, and it's easy to see why Wall Street is so bullish on Amazon's future. On a final note, Amazon is currently selling for roughly 37 times trailing-12-month earnings. While that's a premium, it's well below the stock's three-year average multiple of 83, so from a historical standpoint, it's a bargain. I'd suggest that's a reasonable price to pay for a stock that gained 95% over the past three years, far exceeding the 61% gains of the S&P 500. For those reasons and more, Amazon stock is a buy. Before you buy stock in Amazon, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Amazon wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $671,477!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,010,880!* Now, it's worth noting Stock Advisor's total average return is 1,047% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of July 7, 2025 John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Danny Vena has positions in Amazon and Roku. The Motley Fool has positions in and recommends Amazon and Roku. The Motley Fool has a disclosure policy. Should You Buy Amazon Stock Before July 31? was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Morningstar Expects ASML Holding (ASML) to Remain Top Lithography Equipment Provider
Morningstar Expects ASML Holding (ASML) to Remain Top Lithography Equipment Provider

Yahoo

time23 minutes ago

  • Yahoo

Morningstar Expects ASML Holding (ASML) to Remain Top Lithography Equipment Provider

ASML Holding N.V. (NASDAQ:ASML) is one of the 10 Best Semiconductor Stocks to Buy According to Reddit. Morningstar believes that the company will remain the top lithography equipment provider in semiconductor foundries for a minimum of the next 2 decades. The other companies have redesigned their fabs a decade ago in order to make them suitable for extreme ultraviolet, or EUV, lithography, which happens to be a costly and long endeavor. Therefore, Morningstar opines that ASML Holding N.V. (NASDAQ:ASML) is not likely to be displaced from its place. A technician in a clean room working on a semiconductor device, illuminated by the machines. Furthermore, no competitor has been able to match ASML Holding N.V. (NASDAQ:ASML)'s technological leadership. Its competitive advantage is expected to continue to expand further, added the firm. ASML Holding N.V. (NASDAQ:ASML)'s leading market position further strengthens its key role in the broader global semiconductor supply chain. Its EUV technology, critical for producing advanced logic and memory chips, has supported it in being regarded as an indispensable partner for the semiconductor manufacturers. In Q1 2025, ASML Holding N.V. (NASDAQ:ASML) saw total net sales of €7.7 billion, gross margin of 54.0%, and net income of €2.4 billion, with quarterly net bookings coming at €3.9 billion, of which €1.2 billion is EUV. Parnassus Investments, an investment management company, released its Q1 2025 investor letter. Here is what the fund said: 'In Information Technology, we moved from an underweight to an overweight as we added new positions in Synopsys, ASML Holding N.V. (NASDAQ:ASML) and AppFolio while selling Adobe and Procore Technologies. ASML is a leading supplier of photolithography systems, equipment crucial for producing advanced microchips. It has a wide moat built on technology innovation, high market share and strong customer and supplier relationships.' While we acknowledge the potential of ASML as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio

These Growth Stocks Soared 150% or More in the Last 5 Years and Are Still Great Buys
These Growth Stocks Soared 150% or More in the Last 5 Years and Are Still Great Buys

Yahoo

time30 minutes ago

  • Yahoo

These Growth Stocks Soared 150% or More in the Last 5 Years and Are Still Great Buys

Meta Platforms is hiring top AI talent for its "superintelligence" team. Netflix's improving profit margin could double the stock price by 2030. These 10 stocks could mint the next wave of millionaires › Winners tend to keep on winning in the stock market. The most widely used platforms and services create a windfall of profits for the companies that own them, which can create a self-reinforcing cycle of investment and more growth. This is certainly true for Meta Platforms (NASDAQ: META) and Netflix (NASDAQ: NFLX). These growth stocks have more than doubled since 2020. Here's why they are still excellent investments. Meta Platforms has benefited from a growing social media advertising market. Strong financial results have pushed the stock up 200% since 2020. But the company is making significant investments in artificial intelligence (AI) that could lead to more amazing returns for investors. The company has rolled out the Meta AI personal assistant on all its social media platforms, including Facebook, Instagram, and WhatsApp. It is powered by the company's Llama AI model, and it's becoming one of the most used personal assistants, with around 1 billion monthly active users. Meta is investing around $70 billion annually in technology, and it can afford it. The company generated $66 billion in net income on $170 billion of revenue over the last year. It has the money to buy graphics processing units (GPUs) for AI research, and now it's making a play to bring in the best talent. In just the last few months, management has reportedly hired top executives from OpenAI, Alphabet's Google, Anthropic, and Apple. This talent will form Meta Superintelligence Labs, which will work on Llama and other AI projects and products. CEO Mark Zuckerberg sees a future where AI personal agents are seamlessly integrated into wearables, including glasses (its Ray-Ban Meta AI glasses have already tripled sales over the past year). Wearables, including watches, could become the new iPhone in the next decade, and Meta Platforms is positioning itself to benefit. It has the money, talent, and more than 3.4 billion people using its services every day, yet the stock trades at a reasonable 28 times this year's earnings and 25 times 2026 estimates. This "Magnificent Seven" company is likely worth a lot more than that, and that could spell magnificent returns for investors who buy shares and patiently hold for a decade or more. Shares of Netflix have had an incredible run the past few years. Even if you had bought shares in 2020 and held through the market sell-off in 2022, you would be up 155%. And even at the current $1,276 share price, it's not too late to start an investment in the streaming leader. The Wall Street Journal recently reported that Netflix's internal goal was to double revenue and triple operating income by 2030. In response to an analyst's question about that report on the first-quarter earnings call, management said this doesn't reflect official guidance from the company, but it does see substantial opportunities ahead. Netflix has more than 300 million paid households and more than 700 million viewers. It has a huge audience already, but the streamer's share of TV viewing hours is less than 10%. As co-CEO Greg Peters said, "We still have hundreds of millions of folks to sign up." Analysts expect revenue to grow at a compound annual rate of 11% through 2030, which seems reasonable -- and even lower than the figures reported by the Wall Street Journal. This would bring revenue to $65 billion, up from 2024's $39 billion. However, Netflix is also improving margins, which is fueling robust earnings growth. Earnings jumped 25% year over year in the first quarter, but analysts expect earnings per share to grow at an annualized rate of 20% through 2029 to reach $49.59, up from $19.83 in 2024. Netflix stock currently trades at 50 times this year's earnings estimate. That's expensive, but it has historically traded at a high price-to-earnings multiple, given its recurring revenue from subscriptions. The stock should continue to follow earnings growth, which could double the share price by 2030. Ever feel like you missed the boat in buying the most successful stocks? Then you'll want to hear this. On rare occasions, our expert team of analysts issues a 'Double Down' stock recommendation for companies that they think are about to pop. If you're worried you've already missed your chance to invest, now is the best time to buy before it's too late. And the numbers speak for themselves: Nvidia: if you invested $1,000 when we doubled down in 2009, you'd have $427,709!* Apple: if you invested $1,000 when we doubled down in 2008, you'd have $40,087!* Netflix: if you invested $1,000 when we doubled down in 2004, you'd have $671,477!* Right now, we're issuing 'Double Down' alerts for three incredible companies, available when you join , and there may not be another chance like this anytime soon.*Stock Advisor returns as of July 7, 2025 Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool's board of directors. John Ballard has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Alphabet, Apple, Meta Platforms, and Netflix. The Motley Fool has a disclosure policy. These Growth Stocks Soared 150% or More in the Last 5 Years and Are Still Great Buys was originally published by The Motley Fool Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store